Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

PARKINSON'S DISEASE (CROSBI ID 159766)

Prilog u časopisu | pregledni rad (stručni)

Bene, Raphael ; Antić, Sonja ; Budišić, Mislav ; Lisak, Marijana ; Trkanjec, Zlatko ; Demarin, Vida ; Podobnik-Šarkanji, Slava PARKINSON'S DISEASE // Acta clinica Croatica, 48 (2009), 377-380

Podaci o odgovornosti

Bene, Raphael ; Antić, Sonja ; Budišić, Mislav ; Lisak, Marijana ; Trkanjec, Zlatko ; Demarin, Vida ; Podobnik-Šarkanji, Slava

engleski

PARKINSON'S DISEASE

Parkinson's disease is one of the most common neurodegenerative diseases caused by degeneration of dopaminergic neurons in substantia nigra . The neuropathologic hallmark of Parkinson's disease is the presence of Lewy bodies composed mostly of alpha-synuc1ein and ubiquitin. It is believed that the occurrence of Parkinson's disease is due to a combination of genetic and environmental factors, but the exact mechanism of Parkinson's disease development is not fully elucidated. The most characteristic motor symptoms for Parkinson's disease include bradykinesia, rigidity, resting tremor and postural instability, while many patients also have non-motor signs and symptoms. The key therapeutic agent in the treatment of Parkinson's disease is L-dopa, and the others are dopaminergic agents, monoamine oxidase-B (MAO-B) inhibitors, catechol-O- methyltransferase (COMT) inhibitors, amantadine and anticholinergic agents.

Parkinson disease - etiology; Parkinson disease - diagnosis; Parkinson disease - therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

48

2009.

377-380

objavljeno

0353-9466

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost